WP
COGT icon

Woodline Partners’s Cogent Biosciences COGT Stock Holding History

Woodline Partners’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$101M Buy
2,603,162
+1,093,605
+72% +$38.3M 0.31% 70
2026
Q1 		$58.1M Buy
1,509,557
+690,775
+84% +$25.5M 0.22% 113
2025
Q4 		$29.1M Buy
818,782
+305,385
+59% +$8.58M 0.11% 236
2025
Q3 		$7.37M Sell
513,397
-487,214
-49% -$5.77M 0.03% 497
2025
Q2 		$7.18M Sell
1,000,611
-686,929
-41% -$3.81M 0.04% 492
2025
Q1 		$10.1M Buy
1,687,540
+1,074,375
+175% +$8.42M 0.07% 360
2024
Q4 		$4.78M Buy
613,165
+12,589
+2% +$125K 0.03% 494
2024
Q3 		$6.49M Buy
600,576
+478
+0.1% +$4.65K 0.05% 358
2024
Q2 		$5.06M Sell
600,098
-98,280
-14% -$745K 0.05% 338
2024
Q1 		$4.69M Sell
698,378
-92,106
-12% -$569K 0.04% 368
2023
Q4 		$4.65M Buy
790,484
+670,484
+559% +$5.14M 0.05% 326
2023
Q3 		$1.17M Buy
+120,000
New +$1.42M 0.01% 434
2022
Q4 		– Sell
-69,871
Closed -$1.04M – 769
2022
Q3 		$1.04M Buy
+69,871
New +$958K 0.01% 530
2022
Q2 		– Sell
-36,783
Closed -$276K – 812
2022
Q1 		$276K Buy
+36,783
New +$256K ﹤0.01% 536

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Woodline Partners's COGT Position: Q2 2026 in Review

Woodline Partners increased its Cogent Biosciences (COGT) stake by 72% in Q2 2026, buying an estimated $38.3M and bringing the position to 2,603,162 shares worth $101M. The position accounts for 0.31% of the portfolio, ranked #70.

Woodline Partners first reported a position in COGT in Q1 2022 and has held it in 14 quarters since. 323 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • Woodline Partners held 2,603,162 shares of Cogent Biosciences worth $101M as of Q2 2026.
  • Woodline Partners bought 1,093,605 Cogent Biosciences shares in Q2 2026, an estimated $38.3M.
  • Cogent Biosciences made up 0.31% of Woodline Partners's portfolio in Q2 2026, its #70 holding.
  • Woodline Partners first reported a position in Cogent Biosciences in Q1 2022 and has held it in 14 quarters since.
  • 323 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.